Role of HER2-Related Biomarkers (HER2, p95HER2, HER3, PTEN, and PIK3CA) in the Efficacy of Lapatinib plus Capecitabine in HER2-Positive Advanced Breast Cancer Refractory to Trastuzumab
暂无分享,去创建一个
Tsuyoshi Saito | H. Todoroki | S. Hasegawa | Toshihiro Tanaka | K. Katayama | S. Toyoshima | Y. Ohi | K. Tamura | Maki Tanaka | R. Nishimura | Y. Okumura | N. Arima | S. Mitsuyama | U. Toh | T. Koga | M. Saimura | Y. Kai | Megumi Teraoka | Kazuo Shimada | K. Kurashita